| 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. TA Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A Scientific Reports, 2016 | 1034 | 2016 |
| Modeling neoplastic disease with spheroids and organoids M Zanoni, M Cortesi, A Zamagni, C Arienti, S Pignatta, A Tesei Journal of hematology & oncology 13, 1-15, 2020 | 171 | 2020 |
| Cell counting and viability assessment of 2D and 3D cell cultures: expected reliability of the trypan blue assay F Piccinini, A Tesei, C Arienti, A Bevilacqua Biological procedures online 19, 1-12, 2017 | 121 | 2017 |
| Epidermal growth factor receptor family and its role in gastric cancer C Arienti, S Pignatta, A Tesei Frontiers in oncology 9, 1308, 2019 | 113 | 2019 |
| In vitro preclinical models for a rational design of chemotherapy combinations in human tumors W Zoli, L Ricotti, A Tesei, F Barzanti, D Amadori Critical reviews in oncology/hematology 37 (1), 69-82, 2001 | 112 | 2001 |
| p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients P Ulivi, W Zoli, D Calistri, F Fabbri, A Tesei, M Rosetti, M Mengozzi, ... Journal of cellular physiology 206 (3), 611-615, 2006 | 97 | 2006 |
| Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines P Ulivi, C Arienti, D Amadori, F Fabbri, S Carloni, A Tesei, I Vannini, ... Journal of cellular physiology 220 (1), 214-221, 2009 | 92 | 2009 |
| Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures D Giustarini, F Galvagni, A Tesei, A Farolfi, M Zanoni, S Pignatta, ... Free Radical Biology and Medicine 89, 972-981, 2015 | 90 | 2015 |
| Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines W Zoli, P Ulivi, A Tesei, F Fabbri, M Rosetti, R Maltoni, DC Giunchi, ... Breast Cancer Research 7, 1-9, 2005 | 90 | 2005 |
| The role of mesenchymal stem cells in radiation-induced lung fibrosis M Zanoni, M Cortesi, A Zamagni, A Tesei International journal of molecular sciences 20 (16), 3876, 2019 | 88 | 2019 |
| Anticancer drug discovery using multicellular tumor spheroid models M Zanoni, S Pignatta, C Arienti, M Bonafè, A Tesei Expert opinion on drug discovery 14 (3), 289-301, 2019 | 87 | 2019 |
| Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells F Fabbri, D Amadori, S Carloni, G Brigliadori, A Tesei, P Ulivi, M Rosetti, ... Journal of cellular physiology 217 (2), 494-501, 2008 | 78 | 2008 |
| Concerns, challenges and promises of high-content analysis of 3D cellular models N Carragher, F Piccinini, A Tesei, OJT Jr, M Bickle, P Horvath Nature reviews Drug discovery 17 (8), 606-606, 2018 | 74 | 2018 |
| Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells L Gibellini, M Pinti, F Boraldi, V Giorgio, P Bernardi, R Bartolomeo, M Nasi, ... The FASEB Journal 28 (12), 5122-5135, 2014 | 68 | 2014 |
| Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer W Zoli, L Ricotti, M Dal Susino, F Barzanti, GL Frassineti, S Folli, A Tesei, ... British journal of cancer 81 (4), 609-615, 1999 | 67 | 1999 |
| Cancer multicellular spheroids: volume assessment from a single 2D projection F Piccinini, A Tesei, C Arienti, A Bevilacqua Computer methods and programs in biomedicine 118 (2), 95-106, 2015 | 66 | 2015 |
| Sigma receptors as endoplasmic reticulum stress “gatekeepers” and their modulators as emerging new weapons in the fight against cancer A Tesei, M Cortesi, A Zamagni, C Arienti, S Pignatta, M Zanoni, M Paolillo, ... Frontiers in pharmacology 9, 343729, 2018 | 64 | 2018 |
| Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts C Leonetti, M Scarsella, G Zupi, W Zoli, D Amadori, L Medri, F Fabbri, ... Molecular cancer therapeutics 5 (4), 919-926, 2006 | 59 | 2006 |
| Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ... Oncotarget 7 (14), 18424, 2016 | 56 | 2016 |
| In Vitro Schedule-dependent Interaction between Docetaxel and Gemcitabine in Human Gastric Cancer Cell Lines L Ricotti, A Tesei, F De Paola, P Ulivi, GL Frassineti, C Milandri, ... Clinical cancer research 9 (2), 900-905, 2003 | 56 | 2003 |
Filippo PiccininiBiomedical Engineer, Ph.D in Information Technology, University of Bologna, IRST IRCCS MeldolaVerified email at unibo.it
